Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 1,313 | 436 | 897 | 2,812 |
| Receivables | 81 | 20 | 15 | 74 |
| TOTAL | $2,263 | $633 | $1,070 | $3,071 |
| Non-Current Assets | ||||
| Intangibles | 3,977 | 4,515 | 5,051 | 5,587 |
| TOTAL | $3,977 | $4,515 | $5,051 | $5,587 |
| Total Assets | $6,241 | $5,148 | $6,121 | $8,658 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 1,419 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 421 | 80 | 28 | 40 |
| TOTAL | $1,942 | $155 | $107 | $114 |
| Non-Current Liabilities | ||||
| Long Term Debt | N/A | 1,333 | N/A | N/A |
| TOTAL | $0 | $1,333 | $0 | $0 |
| Total Liabilities | $1,942 | $1,488 | $107 | $114 |
| Shareholders' Equity | ||||
| Common Shares | 16,448 | 13,597 | 13,579 | 13,575 |
| Retained earnings | -14,998 | -10,925 | -8,312 | -5,521 |
| Other shareholders' equity | 3 | 78 | 0 | 0 |
| TOTAL | $4,299 | $3,660 | $6,014 | $8,544 |
| Total Liabilities And Equity | $6,241 | $5,148 | $6,121 | $8,658 |